Page last updated: 2024-09-04

moxifloxacin and Wet Macular Degeneration

moxifloxacin has been researched along with Wet Macular Degeneration in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Daneman, N; Eng, KT; Kertes, PJ; Kohly, R; Lam, WC; Mandelcorn, E; Schwartz, C; Simor, A; Weisbrod, DJ; Yin, VT1
Beránek, J; Hejsek, L; Rencová, E; Rozsíval, P; Rysková, L; Studnicka, J1

Other Studies

2 other study(ies) available for moxifloxacin and Wet Macular Degeneration

ArticleYear
Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection.
    JAMA ophthalmology, 2013, Volume: 131, Issue:4

    Topics: Administration, Topical; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Humanized; Aza Compounds; Bacteria; Ceftazidime; Cohort Studies; Conjunctiva; Drug Resistance, Multiple, Bacterial; Endophthalmitis; Female; Fluoroquinolones; Hospitals, Teaching; Humans; Intravitreal Injections; Male; Microbial Sensitivity Tests; Moxifloxacin; Prospective Studies; Quinolines; Ranibizumab; Wet Macular Degeneration

2013
[Evaluation of bacterial colonization of the conjunctival sac in ranibizumab intravitreal injections treated patients].
    Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti, 2012, Volume: 68, Issue:2

    Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Aza Compounds; Bacteria; Conjunctiva; Drug Combinations; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Intravitreal Injections; Male; Moxifloxacin; Povidone-Iodine; Quinolines; Ranibizumab; Wet Macular Degeneration

2012